Fate Therapeutics Inc FATE

‎$‎1.170(0%)(1D)

• Delayed prices by NASDAQ • in USD

Analyst Forecast

Consensus

Hold

Price Target

2.50

Based on analysts who covered FATE

Invest in Fate Therapeutics Inc
Today

Create an eToro account to buy FATE stock on a secure, user-friendly, multi-asset trading platform.

Fate Therapeutics Inc FATE

Buy FATE

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Cathay Pacific Airways

‎$‎12.33

-5.08%

APEI

American Public Education Inc

Himax Technologies Inc-ADR

‎$‎9.84

-2.86%

HVPE.L

HarbourVest Global Private Equity Ltd

Fate Therapeutics Inc News

Fate Therapeutics (FATE) Reports Strong Q4 Performance and Progress in CAR T-cell Therapy

MAX

*Past performance is not an indication of future results

Jump to:

About FATE >
How to Buy? >
News >
Top Guides >

The Fate Therapeutics Inc share price is stable this week.

The Fate Therapeutics Inc share price today is ‎$‎1.17, reflecting a ‎0‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of FATE is ‎$‎136.03M with an average volume in the last three months of 1.67M. The stock has a P/E ratio of -1.02 and a dividend yield of 0%. With the stock’s beta sitting at 1.67

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

FATE Key Metrics

Market Cap

‎$‎136.03M

Day’s Range

‎$‎1.11 - ‎$‎1.22

52W Range

‎$‎0.641 - ‎$‎4.15

Average Volume (3M)

1.67M

Price-Earnings Ratio

-1.02

Revenue

‎$‎6.65M

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎1.17

EPS

‎$‎-1.15

Beta

1.67

How can I buy Fate Therapeutics Inc stocks?

To purchase Fate Therapeutics Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Fate Therapeutics Inc (FATE) page and place an order to buy Fate Therapeutics Inc.

Buy FATE

Looking for more information? Check out our guide on Academy.

What Is Fate Therapeutics Inc?

Fate Therapeutics is an American biopharmaceutical company founded in 2007 and based in San Diego, California. The organisation specialises in the development of programmed cellular immunotherapies for cancer and immune disorders. It serves healthcare professionals across the USA, manufacturing a range of therapies based on their iPSC-derived cell product candidates.

Fate Therapeutics bases their cellular immunotherapies on their novel ex vivo cell programming approach. The company is development focus is centred on programmed cellular immunotherapies for patients with cancer, including both off-the-shelf T-cell and natural killer product candidates. This innovative and specialist healthcare company collaborates with numerous respected partners, including Janssen Biotech, ONO Pharmaceutical Co. and the Masonic Cancer Centre at the University of Minnesota. These collaborations have led to advancements in the first-ever iPSC-derived cell therapy — FT500 — and the first-ever engineered iPSC-derived cell therapy — FT516. This led to the clinical development of these therapies in the United States.

Stock for Fate Therapeutics is listed on the NASDAQ GS stock exchange under the ticker FATE. The company’s stock has been listed on the exchange since 2013. Fate Therapeutics operates its business through several subsidiaries, including Fate Therapeutics (Canada), Inc. and Fate Therapeutics Ltd.

Track FATE share price changes by adding it to your eToro watchlist.

CEO

Bahram Valamehr, PhD, MBA

Employees

161

Founded

2007

San Diego, California, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Fate Therapeutics Inc
Today

Create an eToro account to buy FATE stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Fate Therapeutics Inc stock?

The current price of FATE is ‎$‎1.17.

What is Fate Therapeutics Inc’s stock future price target?

The average price target for Fate Therapeutics Inc is ‎$‎2.50. Sign up to eToro for detailed analyst forecasts and price targets.

What are analysts’ forecasts for Fate Therapeutics Inc?

Analysts offer forecasts for Fate Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Fate Therapeutics Inc?

The market capitalisation of Fate Therapeutics Inc is ‎$‎136.03M

Is Fate Therapeutics Inc stock buy, sell or hold?

Based on 1 analysts offering recommendations for FATE in the last 3 months, the overall consensus is Hold.

Daily Movers

Explore the biggest stocks movers on the market.